Early Outcomes Using Hepatitis C-Positive Donors for Cardiac Transplantation in the Era of Effective Direct-Acting Antiviral Treatments

Journal of Cardiac Failure- United States

doi 10.1016/j.cardfail.2017.07.027

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Direct Acting Antiviral Regimens Usher in the Era of HCV Positive Donors in Lung Transplant

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Systematic Review: Current Concepts and Challenges for the Direct-Acting Antiviral Era in Hepatitis C Cirrhosis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Barriers to Care for Chronic Hepatitis C in the Direct-Acting Antiviral Era: A Single-Centre Experience

BMJ Open Gastroenterology
Gastroenterology
2017English

Predicting Early Viral Control Under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers

Frontiers in Immunology
AllergyImmunology
2018English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Concerns About Direct-Acting Antiviral Agents for Hepatitis C—Cause for Reassurance

JAMA network open
Medicine
2019English

Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis

Hepatoma Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy